Who owns the DE SIMONE FORMULATION trademark?

The DE SIMONE FORMULATION trademark is owned by ExeGi Pharma, LLC.

What class is the DE SIMONE FORMULATION trademark registered in?

The DE SIMONE FORMULATION trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for DE SIMONE FORMULATION?

The USPTO serial number for DE SIMONE FORMULATION is 88794812.

What is the registration number for DE SIMONE FORMULATION?

DE SIMONE FORMULATION is registered under USPTO registration number 6721007.

DES

USPTO Trademark Record

REGISTERED

DE SIMONE FORMULATION

SN 88794812·Reg 6721007·Filed Feb 12, 2020

Owner ExeGi Pharma, LLC

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

DE SIMONE FORMULATION (Serial No. 88794812), Registration No. 6721007, is a registered US trademark filed on Feb 12, 2020 by ExeGi Pharma, LLC. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: May 24, 2028

Mark Intelligence

DE SIMONE FORMULATION (Reg. #6721007) is a registered US trademark that has been protecting its owner, ExeGi Pharma, LLC, since 2020. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Feb 12, 2020

SERIAL

88794812

REG#

6721007

REGISTERED

May 24, 2022

Owner

Applicant

ExeGi Pharma, LLC

Entity

LLC

State

Address

90 Church Street, Rockville, MD, 20850

Country

Attorney

NameJohn W. McGlynn

Law firm

John W. McGlynn RATNERPRESTIA

Docket

EXG-102US

Address

2200 RENAISSANCE BOULEVARD, SUITE 350, KING OF PRUSSIA, PA 19406, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateFeb 12, 2020

Serial Number88794812

Registration No.6721007

Registration DateMay 24, 2022

Status DateMay 24, 2022

Published for OppositionFeb 22, 2022

Mark TypeStandard characters

Attorney DocketEXG-102US

Status DescriptionLive and registered

Filing Signals

FILED

2020

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

First use anywhere: Nov 30, 2015

First use in commerce: Nov 30, 2015

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

27 events

NOTICE OF REGISTRATION CONFIRMATION EMAILED

May 24, 2022

NOTICE OF REGISTRATION CONFIRMATION EMAILED

REGISTERED-PRINCIPAL REGISTER

May 24, 2022

REGISTERED-PRINCIPAL REGISTER

PUBLISHED FOR OPPOSITION

Feb 22, 2022

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Feb 22, 2022

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Feb 02, 2022

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 18, 2022

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS/EMAIL CORRESPONDENCE ENTERED

Dec 23, 2021

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS REQUEST FOR RECONSIDERATION RECEIVED

Dec 22, 2021

TEAS REQUEST FOR RECONSIDERATION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Dec 22, 2021

CORRESPONDENCE RECEIVED IN LAW OFFICE

NOTIFICATION OF FINAL REFUSAL EMAILED

Jun 24, 2021

NOTIFICATION OF FINAL REFUSAL EMAILED

FINAL REFUSAL E-MAILED

Jun 24, 2021

FINAL REFUSAL E-MAILED

FINAL REFUSAL WRITTEN

Jun 24, 2021

FINAL REFUSAL WRITTEN

TEAS/EMAIL CORRESPONDENCE ENTERED

Jun 02, 2021

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jun 01, 2021

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jun 01, 2021

CORRESPONDENCE RECEIVED IN LAW OFFICE

NON-FINAL ACTION WRITTEN

Nov 30, 2020

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Nov 30, 2020

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Nov 30, 2020

NOTIFICATION OF NON-FINAL ACTION E-MAILED

TEAS/EMAIL CORRESPONDENCE ENTERED

Nov 06, 2020

TEAS/EMAIL CORRESPONDENCE ENTERED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Nov 06, 2020

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Nov 06, 2020

TEAS RESPONSE TO OFFICE ACTION RECEIVED

NON-FINAL ACTION WRITTEN

May 06, 2020

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

May 06, 2020

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

May 06, 2020

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Apr 30, 2020

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Feb 18, 2020

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Feb 15, 2020

NEW APPLICATION ENTERED

DE SIMONE FORMULATION

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by ExeGi Pharma, LLC

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by John W. McGlynn

Resources

Company